Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform

Collaboration provides direct access to three competitively priced biosimilars through a transparent pricing model across immunology and inflammatory diseasesCHICAGO and LAKE ZURICH, Ill, Sept. 29, 2026 // -- Waltz Health®, an EVERSANA® company developing technologies and services that su…